Senior Director, Global Strategic Account Management

Join Us in Changing Lives

At OXB, our people are at the heart of everything we do. We're on a mission to enable life-changing therapies to reach patients around the world-and we're looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful.

We are currently recruiting for Sr Director, Global Strategic Account Management to join the Global Commercial team.  The role is responsible for developing and executing the global account strategy for a portfolio of strategic customers. This role drives profitable revenue growth, strengthens executive-level customer relationships, identifies new business opportunities, and ensures alignment between customer objectives and company capabilities, playing a key part in advancing our mission and making a real difference.

This role can be located close by one of our global locations in Oxford, UK, Durham, NC, US, or Strasbourg or Lyon in France.

Your responsibilities in this role would be to:

• Develop and execute global strategic account plans for assigned Cell & Gene Therapy customers.
• Build trusted relationships with executive sponsors, C-suite leaders, and technical stakeholders.
• Lead high-value customer relationships from early development through commercial supply, aligning customer pipelines with Contract Development Manufacturing Organisation (CDMO capabilities)
• Drive profitable growth through programme expansion, strategic account penetration, contract renewals, and commercial negotiations.
• Lead executive business reviews, governance meetings, and portfolio planning discussions.
• Align customer expectations with operational capabilities and resolve complex commercial, operational, quality, or supply issues.
• Maintain strong knowledge of Cell & Gene Therapy markets, competitors, regulations, and emerging technologies, while representing the company at industry and executive events.

We are looking for :

• Bachelor's or Master's qualification in life sciences or business; a PhD and/or MBA is desirable.
• Extensive experience in life sciences, pharmaceuticals, CDMOs, or related sectors, preferably including cell and gene therapy.
• Significant B2B business development, sales, or marketing experience, ideally within pharmaceutical services.
• Strong understanding of process development and GMP manufacturing projects across pharma and biotech.
• Knowledge of CDMO commercial terms, contract structures, and collaboration with external legal advisers.
• Proven ability to win CDMO business, develop compelling value propositions, and create mutually beneficial commercial solutions.
• Ability to guide clients towards novel viral-vector GMP manufacturing solutions and collaborate closely with customer-facing and internal teams.

This role does not offer sponsorship for work authorization. External applicants must be eligible to work in within the country they are looking to be based.

About Us:

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world's most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB's world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.

OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.

Why Join Us?

• Competitive total reward packages
• Wellbeing programs that support your mental and physical health
• Career development opportunities to help you grow and thrive
• Supportive, inclusive, and collaborative culture
• State-of-the-art labs and manufacturing facilities
• A company that lives its values: Responsible, Responsive, Resilient, Respect

We want you to feel inspired every day. At OXB, we're future-focused and growing fast. We succeed together-through passion, commitment, and teamwork.

The closing date for applications is Friday 16th October 2026

Please note: Our vacancies are typically advertised for a minimum of 10 working days. Once a vacancy closes, it may take a few days for us to provide an update while our Talent Acquisition team and Hiring managers review all applications.

Every application is reviewed manually by our recruitment team and hiring managers. We do not use AI to screen CVs or make shortlisting decisions.